Fifth Third Bancorp
TERN

Fifth Third Bancorp’s Terns Pharmaceuticals TERN Stock Holding History

Fifth Third Bancorp’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-605
Closed -$31.9K – 4446
2026
Q1 		$31.9K Buy
+605
New +$24.9K ﹤0.01% 3356

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Fifth Third Bancorp's TERN Position: Q2 2026 in Review

Fifth Third Bancorp sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 605 shares — an estimated $31.9K sold.

Fifth Third Bancorp first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $31.9K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Fifth Third Bancorp reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Fifth Third Bancorp sold 605 Terns Pharmaceuticals shares in Q2 2026, an estimated $31.9K.
  • Fifth Third Bancorp first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Fifth Third Bancorp's Terns Pharmaceuticals position peaked at $31.9K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.